The study disclosed that urinary KIM-1 and neutrophil gelatinase-associated lipocalin (NGAL) were promising biomarkers in discriminating between patients with and without VA-AKI earlier than serum creatinine [63]. This evidence concerns the gene LCN2 and acute kidney injury.